Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimer Dis Assoc Disord

Retrieve available abstracts of 65 articles:
HTML format



Single Articles


    August 2025
  1. PEREIRA DA SILVA AM, Falcao Carneiro Filho L, Virgilio Ribeiro F, Rodrigues Menezes I, et al
    Efficacy, Immunogenicity, Safety, and Tolerability of AADvac1 in Alzheimer Disease: A Systematic Review and Meta-Analysis of Placebo-Controlled Trials.
    Alzheimer Dis Assoc Disord. 2025 Aug 18. doi: 10.1097/WAD.0000000000000686.
    PubMed     Abstract available


    May 2025
  2. MALEK-AHMADI M, Schack K, Duff K, Koppelmans V, et al
    Cortical Thickness Predictors of Performance-Based Functional Task Variability in the Alzheimer Disease Spectrum.
    Alzheimer Dis Assoc Disord. 2025 May 13. doi: 10.1097/WAD.0000000000000672.
    PubMed     Abstract available


  3. LEAL-BERNAL C, Noriega-Ramirez S, Alvarez-Martinez JV, Cifuentes-Gonzalez C, et al
    Retinal and Vascular Findings in Optical Coherence Tomography in Healthy Cognitive Patients With Alzheimer Disease Biomarkers: A Systematic Review and Meta-Analysis.
    Alzheimer Dis Assoc Disord. 2025 May 13. doi: 10.1097/WAD.0000000000000669.
    PubMed     Abstract available


  4. RYMAN SG, Verney SP, Quam M, Ghahate D, et al
    Language Dominance and Education Considerations in the Neuropsychological Assessment of Southwestern American Indians Using the National Alzheimer Coordinating Center's Uniform Data Set Version 3.
    Alzheimer Dis Assoc Disord. 2025 May 9. doi: 10.1097/WAD.0000000000000668.
    PubMed     Abstract available


    April 2025
  5. LUCHSINGER JA, Devanand D, Goldberg TE, Cammack S, et al
    Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP).
    Alzheimer Dis Assoc Disord. 2025;39:123-133.
    PubMed     Abstract available


    January 2025
  6. NAKAMURA Y, Omori T, Nishiyama K, Ishikawa I, et al
    Effect of Social Restriction Due to the COVID-19 Pandemic on Activity of Daily Living and Disease Severity of Patients With Alzheimer Disease: Sub-analysis of a Double-blinded Noninferiority Study of Donepezil Patches and Donepezil Tablets.
    Alzheimer Dis Assoc Disord. 2025 Jan 31. doi: 10.1097/WAD.0000000000000657.
    PubMed     Abstract available


  7. SCHIEL A, Brogaard NJ, Hahn-Pedersen J, Schlueter M, et al
    Time Delay: Searching for a Meaningful Outcome of Disease Modification in Alzheimer Disease: A Report of the Educational Symposium Held at ISPOR Europe 2023.
    Alzheimer Dis Assoc Disord. 2025 Jan 10. doi: 10.1097/WAD.0000000000000654.
    PubMed    


  8. CAYIR S, Sadabad FE, Mecca AP, Matuskey D, et al
    Cerebrospinal Fluid Biomarkers and Cognition in Alzheimer Disease and Frontotemporal Dementia in a Memory Clinic Setting.
    Alzheimer Dis Assoc Disord. 2025;39:22-27.
    PubMed     Abstract available


    November 2024
  9. RANGEL DA SILVA RC, Neto JPS, Belfort T, Dourado MCN, et al
    Social and emotional self-perception in people with mild to moderate Alzheimer disease compared to caregiver's perspective in Brazil.
    Alzheimer Dis Assoc Disord. 2024 Nov 8. doi: 10.1097/WAD.0000000000000651.
    PubMed     Abstract available


    October 2024
  10. TAY SY, Koay WI, Ting SKS, Liew TM, et al
    Examining the Measurement Equivalence of Alzheimer Disease Research Centers' Neuropsychological Test Battery (Version 3) Between Singapore and US Samples.
    Alzheimer Dis Assoc Disord. 2024 Oct 28. doi: 10.1097/WAD.0000000000000649.
    PubMed     Abstract available


  11. KIDANA K, Yamaga R, Fujii H, Akishita M, et al
    Discontinuation of Alzheimer Disease Medications in Patients Receiving Home Care Medicine.
    Alzheimer Dis Assoc Disord. 2024 Oct 28. doi: 10.1097/WAD.0000000000000650.
    PubMed     Abstract available


  12. NAKAMURA Y, Omori T, Nishiyama K, Ishikawa I, et al
    Effect of Social Isolation Due to the COVID-19 Pandemic on Cognitive Dysfunction of Patients With Alzheimer Disease: Subanalysis of Double-blinded Noninferiority Study of Donepezil Patches and Donepezil Tablets.
    Alzheimer Dis Assoc Disord. 2024;38:351-357.
    PubMed     Abstract available


  13. TAHMI M, Rippon B, Palta P, Sherwood G, et al
    Relationship Between Alzheimer Disease Imaging Biomarkers and Performance on the NIH Toolbox Cognition Battery in Late-middle Age Hispanics.
    Alzheimer Dis Assoc Disord. 2024;38:311-318.
    PubMed     Abstract available


    September 2024
  14. CARMEL JF, Clerc D, Couture V, Reid I, et al
    The Difference in Cognitive Profiles Between Patients With Alzheimer Dementia With and Without Psychosis: A Rapid Review.
    Alzheimer Dis Assoc Disord. 2024 Sep 25. doi: 10.1097/WAD.0000000000000644.
    PubMed     Abstract available


    August 2024
  15. BRETECHER CA, Verot A, Teschuk JM, Uehara MA, et al
    Quantitative Analysis of Factors of Attrition in a Double-blind rTMS Study for Alzheimer Treatment.
    Alzheimer Dis Assoc Disord. 2024 Aug 8. doi: 10.1097/WAD.0000000000000633.
    PubMed     Abstract available


  16. TAHERI SOODEJANI M, Rasoulian Kasrineh M, Tabatabaei SM
    Incidence of Alzheimer Disease and Related Dementias in Iran From 2000 to 2019.
    Alzheimer Dis Assoc Disord. 2024 Aug 5. doi: 10.1097/WAD.0000000000000628.
    PubMed     Abstract available


    July 2024
  17. GUIDO G, Bonato A, Bonomi S, Franceschini S, et al
    Handedness in Alzheimer Disease: A Systematic Review.
    Alzheimer Dis Assoc Disord. 2024;38:298-304.
    PubMed     Abstract available


  18. BOZEK A, Pawlowicz R, Spyra A, Tekiela N, et al
    Frequent Occurrence of Alzheimer Disease in Patients With IgE-mediated Allergies.
    Alzheimer Dis Assoc Disord. 2024;38:295-297.
    PubMed     Abstract available


  19. PEAVY GM, Vo N, Revta C, Lu AT, et al
    Asian Cohort for Alzheimer Disease (ACAD) Pilot Study: Vietnamese Americans.
    Alzheimer Dis Assoc Disord. 2024;38:277-284.
    PubMed     Abstract available


  20. UCHEAGWU V, Odilora C, Ugokwe-Joseph R, Giordani B, et al
    Factor Structure and Internal Consistency of the National Alzheimer Coordinating Center's Uniform Data Set Version 3 Neuropsychological Test Battery (UDSNB 3.0): The Nigeria Sample.
    Alzheimer Dis Assoc Disord. 2024;38:265-270.
    PubMed     Abstract available


  21. ASCHENBRENNER AJ, Carr DB, Benzinger TLS, Morris JC, et al
    The Influence of Personality Traits on Driving Behaviors in Preclinical Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2024;38:241-248.
    PubMed     Abstract available


    May 2024
  22. MORIN P, Aguilar BJ, Berlowitz D, Zhang R, et al
    Clinical Characterization of Veterans With Alzheimer Disease by Disease Severity in the United States.
    Alzheimer Dis Assoc Disord. 2024 May 17. doi: 10.1097/WAD.0000000000000622.
    PubMed     Abstract available


  23. BRIGGS AQ, Ouedraogo Tall S, Boza-Calvo C, Bernard MA, et al
    Drivers of Memory Loss Underreport in Mild Cognitive Impairment Due to Alzheimer Versus Vascular Disease.
    Alzheimer Dis Assoc Disord. 2024 May 17. doi: 10.1097/WAD.0000000000000627.
    PubMed     Abstract available


  24. HAGHDEL A, Smith N, Glodzik L, Li Y, et al
    Evidence of Pericyte Damage in a Cognitively Normal Cohort: Association With CSF and PET Biomarkers of Alzheimer's Disease.
    Alzheimer Dis Assoc Disord. 2024 May 16. doi: 10.1097/WAD.0000000000000623.
    PubMed     Abstract available


  25. TERESI JA, Ocepek-Welikson K, Eimicke JP, Ramirez M, et al
    Measurement of Allostatic Load in Caregivers of Older Hispanic People With Alzheimer Disease and Related Disorders.
    Alzheimer Dis Assoc Disord. 2024 May 16. doi: 10.1097/WAD.0000000000000625.
    PubMed     Abstract available


    April 2024
  26. JUNG NY, Je Y, Ham HG, Park YH, et al
    Comparison of Enlarged Perivascular Spaces in Early-Onset and Late-Onset Alzheimer Disease-related Cognitive Impairment: A Single Clinic-based Study in South Korea.
    Alzheimer Dis Assoc Disord. 2024 Apr 2. doi: 10.1097/WAD.0000000000000614.
    PubMed     Abstract available


  27. BANGERTER LR, Griffin JM, Kim K, Finnie DM, et al
    A Delphi Approach to Define Lucid Episodes in People Living With Dementia.
    Alzheimer Dis Assoc Disord. 2024;38:147-151.
    PubMed     Abstract available


  28. LIU H, Weakley AM, Zhang J, Liu X, et al
    A Transformer Approach for Cognitive Impairment Classification and Prediction.
    Alzheimer Dis Assoc Disord. 2024;38:189-194.
    PubMed     Abstract available


    January 2024
  29. FREDERIKSEN KS, Morato X, Zetterberg H, Gauthier S, et al
    Focusing on Earlier Management of Alzheimer Disease: Expert Opinion Based on a Modified Nominal Group Technique.
    Alzheimer Dis Assoc Disord. 2024 Jan 29. doi: 10.1097/WAD.0000000000000600.
    PubMed     Abstract available


  30. D'SOUZA GM, Churchill NW, Guan DX, Khoury MA, et al
    Interaction of Alzheimer Disease and Traumatic Brain Injury on Cortical Thickness.
    Alzheimer Dis Assoc Disord. 2024 Jan 29. doi: 10.1097/WAD.0000000000000607.
    PubMed     Abstract available


  31. KOBAYASHI R, Morioka D, Kawakatsu S, Sakamoto K, et al
    Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology.
    Alzheimer Dis Assoc Disord. 2024 Jan 17. doi: 10.1097/WAD.0000000000000597.
    PubMed     Abstract available


  32. WERNER P, Ulitsa N, Alpinar-Sencan Z, Shefet D, et al
    Identifying Stigmatizing Language Used by Israelis and Germans With a Mild Neurocognitive Disorder, Their Relatives, and Caregivers of People With Alzheimer's Disease.
    Alzheimer Dis Assoc Disord. 2024 Jan 9. doi: 10.1097/WAD.0000000000000596.
    PubMed     Abstract available


  33. SEWELL M, Neugroschl J, Zhu CW, Loizos M, et al
    Lessons From the Coronavirus Disease Experience: Research Participant and Staff Satisfaction With Remote Cognitive Evaluations.
    Alzheimer Dis Assoc Disord. 2024;38:65-69.
    PubMed     Abstract available


  34. SABBAGH MN, Michalak W, Thim Hansen C, Ahmad Wichmann C, et al
    Rescreening on RBANS Delayed Memory Index? Forget About It!
    Alzheimer Dis Assoc Disord. 2024;38:8-13.
    PubMed     Abstract available


  35. STITES SD, Lee BN, Rubright JD, Harkins K, et al
    Cognitive Complaint Types Can Correlate With Cognitive Testing, Perceived Stress, and Symptom Distress in Older Adults With Normal Cognition and Dementia.
    Alzheimer Dis Assoc Disord. 2024;38:34-41.
    PubMed     Abstract available


    November 2023
  36. BELFORT ALMEIDA DOS SANTOS TT, Nogueira MML, Lacerda IB, Brandt M, et al
    A Longitudinal Evaluation of the Pattern of Social Cognition Impairment in Brazilians With Alzheimer's Disease.
    Alzheimer Dis Assoc Disord. 2023 Nov 2. doi: 10.1097/WAD.0000000000000588.
    PubMed     Abstract available


    October 2023
  37. CLARK LR, Erickson CM, Chin NA, Basche KE, et al
    Anticipated Psychological or Behavioral Reactions to Learning Alzheimer Biomarker Results: Associations With Contextual Factors.
    Alzheimer Dis Assoc Disord. 2023 Oct 12. doi: 10.1097/WAD.0000000000000586.
    PubMed     Abstract available


  38. RAZOUQI Y, El Bouchikhi I, El-Abid H, Baammi S, et al
    Novel APOE Mutation in a Moroccan Subject Suffering from Alzheimer Disease: A Case Study and Exploration of Pathogenic Implication.
    Alzheimer Dis Assoc Disord. 2023;37:370-372.
    PubMed     Abstract available


  39. PLASCHKE K, Kopitz J, Gebert J, Wolf ND, et al
    Proteomic Analysis Reveals Potential Exosomal Biomarkers in Patients With Sporadic Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2023;37:315-321.
    PubMed     Abstract available


  40. MEMBRENO R, Thomas KR, Calcetas AT, Edwards L, et al
    Regional White Matter Hyperintensities Relate to Specific Cognitive Abilities in Older Adults Without Dementia.
    Alzheimer Dis Assoc Disord. 2023;37:303-309.
    PubMed     Abstract available


  41. HONIG LS
    Alzheimer Disease: A New Beginning in Therapeutics.
    Alzheimer Dis Assoc Disord. 2023;37:267-269.
    PubMed    


  42. RAHMAN-FILIPIAK A, Lesniak M, Sadaghiyani S, Roberts S, et al
    Perspectives From Black and White Participants and Care Partners on Return of Amyloid and Tau PET Imaging and Other Research Results.
    Alzheimer Dis Assoc Disord. 2023;37:274-281.
    PubMed     Abstract available


  43. CONCEICAO ASGG, Sant Ana LFG, Mattar GP, de Fatima R Silva M, et al
    Balance and Gait: Associations With Cognitive Impairment and Dementia in Individuals With Down Syndrome.
    Alzheimer Dis Assoc Disord. 2023;37:349-356.
    PubMed     Abstract available


  44. REDFORD E, Heuer S
    A Visual Analog Scale for Self-Reported Quality of Life: A Comparison of VAS and QoL-AD in Older Adults.
    Alzheimer Dis Assoc Disord. 2023;37:343-348.
    PubMed     Abstract available


  45. KANN MR, Zeiger PJ, Rizer SJ, Cosentino S, et al
    Virtual Assessment as a Way to Reduce Help-seeking Barriers in Older Adults With Subjective Cognitive Decline.
    Alzheimer Dis Assoc Disord. 2023;37:373-378.
    PubMed     Abstract available


  46. PLETNIKOVA A, Okhravi HR, Jamil N, Kirby M, et al
    Utility of amyloid PET Imaging in a Memory Clinic.
    Alzheimer Dis Assoc Disord. 2023;37:270-273.
    PubMed     Abstract available


    September 2023
  47. SCHUBERT CR, Paulsen AJ, Pinto AA, Chappell RJ, et al
    Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2023 Sep 13. doi: 10.1097/WAD.0000000000000579.
    PubMed     Abstract available


  48. SABBAGH MN, Mathew P, Blau A
    A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers.
    Alzheimer Dis Assoc Disord. 2023 Sep 11. doi: 10.1097/WAD.0000000000000578.
    PubMed     Abstract available


    August 2023
  49. PROUGH MB, Zaman A, Caywood LJ, Clouse JE, et al
    Visuospatial and Verbal Memory Differences in Amish Individuals with Alzheimer Disease and Related Dementias.
    Alzheimer Dis Assoc Disord. 2023 Aug 2. doi: 10.1097/WAD.0000000000000570.
    PubMed     Abstract available


    July 2023
  50. STRIJKERT F, Huitema RB, van Munster BC, Spikman JM, et al
    Impaired Emotion Recognition: A Potential Marker for Social Behavioral Problems in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer Disease?
    Alzheimer Dis Assoc Disord. 2023 Jul 24. doi: 10.1097/WAD.0000000000000567.
    PubMed     Abstract available


  51. TIDMORE LM, Skrepnek GH
    To the Editor and Readership of Alzheimer Disease and Associated Disorders.
    Alzheimer Dis Assoc Disord. 2023 Jul 5. doi: 10.1097/WAD.0000000000000566.
    PubMed    


  52. KAWADA T
    A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings.
    Alzheimer Dis Assoc Disord. 2023 Jul 5. doi: 10.1097/WAD.0000000000000565.
    PubMed    


  53. CHI YC, Chu WM, Chang HY, Lu TH, et al
    International Variations in Dementia and Alzheimer Disease Diagnosis and Certification Habits and Their Associations With Dementia and Alzheimer Disease Mortality: A Cross-Sectional Study of 38 Countries.
    Alzheimer Dis Assoc Disord. 2023;37:215-221.
    PubMed     Abstract available


    June 2023
  54. TAYEB HO, Butt NS, Khallaf R, Yahghmour B, et al
    Alzheimer's Behavioral and Psychiatric Burden in Saudi Arabia: Validation of the Saudi Version of the Neuropsychiatric Inventory.
    Alzheimer Dis Assoc Disord. 2023 Jun 26. doi: 10.1097/WAD.0000000000000563.
    PubMed     Abstract available


  55. SUGIMURA Y, Baba T, Ezura M, Kikuchi A, et al
    A Case of Corticobasal Syndrome and Posterior Cortical Atrophy With Biomarkers of Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2023 Jun 22. doi: 10.1097/WAD.0000000000000560.
    PubMed     Abstract available


    April 2023
  56. AMIRI S, Jiang L, Manson SM, Buchwald DS, et al
    Trends in Alzheimer Disease Mortality Among American Indian and Alaska Native People Between 2011 and 2019.
    Alzheimer Dis Assoc Disord. 2023 Apr 28. doi: 10.1097/WAD.0000000000000555.
    PubMed     Abstract available


  57. SADHUKHAN D, Mallick A, Mishra S, Mukherjee A, et al
    An Indian Young-onset Dementia With Parkinsonism With Double Heterozygous Mutations in ABCA7 and PRKN Identified Through Whole-exome Sequencing.
    Alzheimer Dis Assoc Disord. 2023;37:164-167.
    PubMed     Abstract available


  58. VAN HEZIK-WESTER VJ, Handels RLH, Wolfs CAG, Kanters TA, et al
    Caregiver Burden and Quality of Life Across Alzheimer's Disease Severity Stages.
    Alzheimer Dis Assoc Disord. 2023;37:134-141.
    PubMed     Abstract available


  59. GABEL M, Denny A, Llibre-Guerra J, Morris JC, et al
    Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority Communities.
    Alzheimer Dis Assoc Disord. 2023;37:107-112.
    PubMed     Abstract available


  60. SHAW AR, Lofton S, Vidoni ED
    A Virtual Photovoice Study of Older African Americans Perceptions of Neurovascular Clinical Trials.
    Alzheimer Dis Assoc Disord. 2023;37:113-119.
    PubMed     Abstract available


  61. MASCARENHAS FONSECA L, Sheppard DP, Chaytor NS
    MoCA Intraindividual Cognitive Variability in Older Adults With Type 1 Diabetes.
    Alzheimer Dis Assoc Disord. 2023;37:152-155.
    PubMed     Abstract available


    January 2023
  62. CALVO N, Anderson JAE, Berkes M, Freedman M, et al
    Gray Matter Volume as Evidence for Cognitive Reserve in Bilinguals With Mild Cognitive Impairment.
    Alzheimer Dis Assoc Disord. 2023;37:7-12.
    PubMed     Abstract available


  63. JIN L, Nawaz H, Ono K, Nowell J, et al
    One Minute of EEG Data Provides Sufficient and Reliable Data for Identifying Lewy Body Dementia.
    Alzheimer Dis Assoc Disord. 2023;37:66-72.
    PubMed     Abstract available


  64. KELLY MJ, Fearon C, O'Dowd S
    Seeing the Woods for the Trees? Applying Diagnostic Criteria for Dementia with Lewy Bodies to Patients Presenting with Posterior Cortical Atrophy.
    Alzheimer Dis Assoc Disord. 2023;37:88-91.
    PubMed     Abstract available


  65. THOMAS Q, Nambot S, Bejot Y, Philippe C, et al
    A New Presenilin-1 Missense Variant Associated With a Progressive Supranuclear Palsy-like Phenotype.
    Alzheimer Dis Assoc Disord. 2023;37:82-84.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.